期刊文献+

糖尿病大鼠白内障免疫球蛋白的实验研究 被引量:2

Experimental study of immunoglobulin in rat diabetic cataract
下载PDF
导出
摘要 目的:糖尿病白内障大鼠不同时间点房水中免疫球蛋白变化,探讨糖尿病性白内障形成的作用机制。方法:以链脲佐菌素建成大鼠糖尿病模型,观察不同时期晶状体的变化情况,利用全自动生化检测仪检测各时间点大鼠房水中免疫球蛋白。结果:糖尿病大鼠晶状体逐渐混浊并随时间推移而加重。正常对照组大鼠房水中IgG含量为0.29±0.01mg/mL,成模后1,2,3mo大鼠房水中IgG含量分别为0.74±0.02,0.87±0.02及1.00±0.05mg/mL;正常对照组大鼠房水中IgA含量为1.67±0.01mg/mL,成模后1,2,3mo含量分别为4.23±0.01,4.42±0.01及10.56±0.07mg/mL;正常对照组大鼠房水中Alb含量为10.93±0.01mg/mL,成模后1,2,3mo含量分别为210.00±1.00,2200.00±2.64及5900.00±3.92mg/mL;正常对照组大鼠房水中C3含量为0,成模后1,2,3mo含量分别为10.00±0.01,10.00±0.01及50.00±0.06mg/mL。各组之间差异均具有统计学意义。结论:血-房水屏障发生改变,影响晶状体的正常代谢,是糖尿病性白内障形成的一个重要作用机制。 AIM. To investigate the mechanism of diabetic cataract. METHODS: The animal model of diabetes was introduced by streptozotocin. The changes of lens in different period were observed. Immunoglobulin in aqueous humor was tested using full automatic biochemistry detector. RESULTS: IgG, IgA, AIb and C3 of aqueous humor in diabetic rat was increased with time-lapse. In control group, IgG amount was 0.29 ±0.01mg/mL;The amount of IgG in diabetic rat was 0.74 ±0.02,0.87 ±0.02 and 1.00 ± 0.05mg/mL after 1, 2, and 3 months respectively. In control group, IgA amount was 1.67±0.01mg/mL; The amount of IgA in diabetic rat was 4. 23 ± 0. 01,4. 42 ± 0.01 and 10. 56 ± 0.07mg/mL after 1, 2, and 3 months respectively. In control group, Alb amount was 10.93 ± 0.01mg/mL,The amount of IgA in diabetic rat was 210.00 ± 1.00,2200.00 ± 2.64 and 5900.00 ± 3.92mg/mL after 1, 2, and 3 months respectively. In control group, C3 amount was 0. The amount of IgA in diabetic rat was 10.00 ±0.01,10.00 ±0.01 and 50.00 ±0.06mg/mL after 1,2, and 3 months respectively. There were significant differences among groups. CONCLUSION: Changing of blood-aqueous barrier affect the normal metabolism of the lens, this is an important mechanism of diabetic cataract formation.
出处 《国际眼科杂志》 CAS 2009年第5期848-850,共3页 International Eye Science
关键词 糖尿病 大鼠 晶状体 免疫球蛋白 diabetes mellitus rats lens immunoglobulin
  • 相关文献

参考文献10

二级参考文献30

  • 1韩秀娴,徐辉碧,杨国华,程驿,鲍玉洲,陆家政,周全,周井泉.活性氧自由基诱导白内障的机理研究[J].眼科研究,1993,11(3):225-229. 被引量:6
  • 2张尧贞.老年性白内障的病因[J].中华眼科杂志,1995,31(3):236-238. 被引量:10
  • 3叶山东,朱禧星.非胰岛素依赖型糖尿病患者视网膜病变有关因素分析[J].中国糖尿病杂志,1996,4(1):10-12. 被引量:9
  • 4陈灏珠 李宗明.内科学(第四版)[M].北京:人民卫生出版社,1997.411-412.
  • 5周云平 张家庆.醛糖还原酶抑制剂Sorbinil的临床应用[J].中华内分泌代谢杂志,1988,4(1):45-45.
  • 6蒋国颜.实用糖尿病学[M].北京:人民卫生出版社,1992.166.
  • 7毛文书 李绍珍 等.中国医学百科全书眼科分册[M].上海科技出版社,1985.93-96.
  • 8徐度.自由基生物学与组织损伤的病理机理[J].国外医学眼科分册,1987,11(1):1-1.
  • 9商福.白内障与自由基[J].国外医学眼科分册,1989,13(5):297-297.
  • 10Stambuk N, Curkovic T, Trbojevic-Cepe M, et al. Measurement of intraocular IgA and IgM synthesis and filtraionthrough the blood-aqueous barrier in cataract patients. Curr Eye Res, 1990,9 : 45.

共引文献50

同被引文献16

  • 1刘学丽,朱延勤,潘伟娜,严汉英.对大鼠半乳糖性白内障实验模型的探讨[J].北京实验动物科学与管理,1994,11(2):2-3. 被引量:17
  • 2张晓融,张亚超,宋秀君.牛磺酸与卡林-U滴眼液对实验性白内障大鼠治疗作用的比较[J].中国药房,2005,16(5):342-345. 被引量:1
  • 3刘静霞,张晓冬,吕瑞民,孙河,刘侠,张晓辉,滕晓明.决明退障丸对亚硒酸钠性白内障大鼠脂质过氧化的影响[J].中国中医药科技,2005,12(3):143-145. 被引量:9
  • 4朱宝义,郭勇,王永强.糖尿病性白内障动物模型的建立与评价[J].南方医科大学学报,2006,26(5):707-708. 被引量:6
  • 5He S Z. Anatomy biochemistry and histomorphology of the lens [ M ]. Bcijing : People's Medical Publishing House,2004:3 - 11.
  • 6Anil KP, Bhanuprakash RG. Focus on molecules: aldose reductase[ J]. Exp Eye Res, 2007, 85 (6) :739 - 740.
  • 7Kubo E, Urakami T, Fatma N, et al. Polyol pathway-dependent osmotic and oxidative stresses in aldose reductase-mediated apoptosis in human lens epithelial cells: role of AOP2 [J]. Biochem Biophys Res Commun, 2004, 314(4) :1050 -1056.
  • 8Suzen S, Buyukbingol E. Recent studies of aldose reductase enzyme inhibition for diabetic complications [J]. Curr Med Chem, 2003,10(15) :1329 -1352.
  • 9Mulhem ML, Madson CJ, Kador PF, et al. Cellular osmolytes reduce lens epithelial cell death and alleviate cataract formation in galactosemic rats [ J]. Mol Vis, 2007,13:1397 -1405.
  • 10Ceulemans J,Ludwig A.Optimisation of carbomer visco-us eye drops:an in vitro experimental design approach us-ing rheological techniques[J].European Journal of Phar-maceutics and Biopharmaceutics,2002,54(1):41.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部